Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza Vaccine

NCT02014168 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Futility

Conditions

Interventions

Sponsor

University of Oxford